200 related articles for article (PubMed ID: 19080698)
1. [Effectiveness and safety of proton pump inhibitor and levofloxacin based first-line triple therapy in the eradication of Helicobacter pylori: a meta-analysis].
Zhang ZF; Zhao G; Liu LN
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2722-5. PubMed ID: 19080698
[TBL] [Abstract][Full Text] [Related]
2. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
3. Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.
Ye CL; Liao GP; He S; Pan YN; Kang YB; Zhang ZY
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):443-55. PubMed ID: 24677603
[TBL] [Abstract][Full Text] [Related]
4. [Eradication of Helicobacter pylori infection in Hungary (1993-2002): a meta-analysis].
Buzás GM
Orv Hetil; 2003 Jun; 144(22):1077-83. PubMed ID: 12847817
[TBL] [Abstract][Full Text] [Related]
5. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
Tong JL; Ran ZH; Shen J; Xiao SD
J Clin Pharm Ther; 2009 Feb; 34(1):41-53. PubMed ID: 19125902
[TBL] [Abstract][Full Text] [Related]
6. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A
Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication.
Janssen MJ; Laheij RJ; de Boer WA; Jansen JB
Aliment Pharmacol Ther; 2005 Feb; 21(4):341-5. PubMed ID: 15709984
[TBL] [Abstract][Full Text] [Related]
8. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
Cai W; Zhou L; Ren W; Deng L; Yu M
Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice.
Van der Poorten D; Katelaris PH
Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1537-42. PubMed ID: 17903237
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Helicobacter pylori infection.
Egan BJ; Marzio L; O'Connor H; O'Morain C
Helicobacter; 2008 Oct; 13 Suppl 1():35-40. PubMed ID: 18783520
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication: role of individual therapy constituents and therapy duration.
Qasim A; O'Morain CA; O'Connor HJ
Fundam Clin Pharmacol; 2009 Feb; 23(1):43-52. PubMed ID: 19207543
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Helicobacter pylori eradication rate of triple combination therapy containing levofloxacin.
Seven G; Cinar K; Yakut M; Idılman R; Ozden A
Turk J Gastroenterol; 2011 Dec; 22(6):582-6. PubMed ID: 22287402
[TBL] [Abstract][Full Text] [Related]
14. Evolution of Helicobacter pylori therapy from a meta-analytical perspective.
Gisbert JP; Pajares R; Pajares JM
Helicobacter; 2007 Nov; 12 Suppl 2():50-8. PubMed ID: 17991177
[TBL] [Abstract][Full Text] [Related]
15. [Treatment for Helicobacter pylori: current criteria].
Vaira D; Zullo A; Ricci C; Gigliotti F; Morini S
Recenti Prog Med; 2007 Nov; 98(11):574-82; quiz 602. PubMed ID: 18044409
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
Navarro-Jarabo JM; Fernández N; Sousa FL; Cabrera E; Castro M; Ramírez LM; Rivera R; Ubiña E; Vera F; Méndez I; Rivas-Ruiz F; Moreno JL; Perea-Milla E
BMC Gastroenterol; 2007 Jul; 7():31. PubMed ID: 17651479
[TBL] [Abstract][Full Text] [Related]
17. Sequential therapy for H. pylori eradication.
Drug Ther Bull; 2011 Sep; 49(9):102-5. PubMed ID: 21921072
[TBL] [Abstract][Full Text] [Related]
18. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.
Zou J; Dong J; Yu X
Helicobacter; 2009 Oct; 14(5):97-107. PubMed ID: 19751434
[TBL] [Abstract][Full Text] [Related]
20. Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection.
Gisbert JP;
Aliment Pharmacol Ther; 2012 Jun; 35(12):1484-5; author reply 1486. PubMed ID: 22582841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
